Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietin: current status.

H F Bunn1

  • 1Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

The Yale Journal of Biology and Medicine
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Signal transduction. How do cells sense oxygen?

Science (New York, N.Y.)·2001
Same author

Cadmium and platinum suppression of erythropoietin production in cell culture: clinical implications.

Blood·2000
Same author

Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells.

Proceedings of the National Academy of Sciences of the United States of America·1999
Same author

Regulation of the erythropoietin gene.

Blood·1999
Same author

Oxygen sensing and signaling: impact on the regulation of physiologically important genes.

Respiration physiology·1999
Same author

Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling.

The Journal of biological chemistry·1999
Same journal

Chrysoeriol-Mediated Neuroprotection in Parkinson's Disease in Mice: Targeting Apoptosis, α-Synuclein Accumulation, and Functional Recovery.

The Yale journal of biology and medicine·2026
Same journal

Musicality is Preserved in Neurodegeneration.

The Yale journal of biology and medicine·2026
Same journal

Burden of Neurological Disorders in Resource-Limited Settings: Lessons from Pakistan for Global Neurology.

The Yale journal of biology and medicine·2026
Same journal

Comparative Analysis of Prenatal Stress Models: Placental and Neurodevelopmental Outcomes in Mice.

The Yale journal of biology and medicine·2026
Same journal

Computational Investigation of Flavonoid-Associated Molecular Pathways in Astrogliosis Modulation.

The Yale journal of biology and medicine·2026
Same journal

Regulation and Interaction Among SOCS1 and SOCS3 by MicroRNAs in Multiple Sclerosis: A Review and <i>In Silico</i> Analysis.

The Yale journal of biology and medicine·2026
See all related articles

Recombinant human erythropoietin (rhEpo) therapy effectively treats anemia in chronic kidney disease and other conditions. rhEpo is revolutionizing transfusion medicine by aiding autotransfusions and reducing post-operative transfusions.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Medicine

Background:

  • Red blood cell production is regulated by erythropoietin (Epo).
  • Cloning the human Epo gene and its receptor advanced understanding.
  • The development of recombinant human erythropoietin (rhEpo) marked a significant advancement.

Purpose of the Study:

  • To review the therapeutic applications of rhEpo.
  • To highlight rhEpo's role in managing anemia.
  • To discuss rhEpo's impact on transfusion medicine.

Main Methods:

  • Review of existing literature on rhEpo.
  • Analysis of clinical outcomes in patients treated with rhEpo.
  • Evaluation of rhEpo's efficacy in various anemia types.

Related Experiment Videos

Main Results:

  • rhEpo reliably cures anemia in chronic renal failure.
  • rhEpo shows effectiveness in treating anemias from chronic inflammation, malignancy, and chemotherapy-induced marrow suppression.
  • rhEpo is valuable in transfusion medicine for autotransfusion preparation and minimizing post-operative transfusions.

Conclusions:

  • rhEpo administration represents a new era in molecular medicine.
  • rhEpo therapy is a cornerstone in managing various types of anemia.
  • rhEpo is poised to play a significant role in optimizing transfusion strategies.